| RS2519918613 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS2519918676 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2519918702 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS2519918709 |
RP2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 2, Retinitis pigmentosa 2 |
| RS2519921731 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519922156 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519922410 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519924091 |
NHS
|
Health Risk |
Pathogenic |
Cataract 40, Ovarian serous cystadenocarcinoma |
| RS2519927267 |
RPGR
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, RPGR-related retinopathy |
| RS2519927471 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519927569 |
NHS
|
Health Risk |
Likely pathogenic |
Nance-Horan syndrome, Cataract 40 |
| RS2519928443 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS2519928455 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS2519928496 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS2519928505 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS2519929432 |
AP1S2
|
Health Risk |
Likely pathogenic |
— |
| RS2519929717 |
AP1S2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519929746 |
AP1S2
|
Health Risk |
Pathogenic |
— |
| RS2519929822 |
AP1S2
|
Health Risk |
Likely pathogenic |
Pettigrew syndrome, Pettigrew syndrome |
| RS2519930695 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2519935536 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519936481 |
ATRX
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2519937826 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519938626 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519938991 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519939810 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519940981 |
NHS
|
Health Risk |
Pathogenic/Likely pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519941556 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519941830 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2519941885 |
NHS
|
Health Risk |
Likely pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS2519941939 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519945087 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2519949224 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2519950487 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519951682 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2519952390 |
OTC
|
Health Risk |
Pathogenic |
— |
| RS2519952395 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519952402 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519954454 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2519959270 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519963370 |
UBQLN2
|
Health Risk |
Likely pathogenic |
UBQLN2-related disorder, UBQLN2-related disorder |
| RS2519972989 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519973556 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519974595 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519975343 |
OTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519975441 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519975452 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519978937 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519979325 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519979361 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519979419 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519979431 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519979459 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519986909 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2519986961 |
OTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS2520005872 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2520012737 |
EFNB1
|
Health Risk |
Pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2520012748 |
EFNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2520012780 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2520012797 |
EFNB1
|
Health Risk |
Pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2520014009 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520014015 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520014175 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520014545 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520014610 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520014655 |
CHM
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2520014875 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS2520014897 |
CHM
|
Health Risk |
Likely pathogenic |
— |
| RS2520018459 |
BCOR
|
Health Risk |
Likely pathogenic |
Oculofaciocardiodental syndrome (OFCD), Oculofaciocardiodental syndrome (OFCD) |
| RS2520020650 |
DMD
|
Health Risk |
Likely pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS2520021065 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2520022633 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2520022878 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2520023216 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2520023450 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2520024317 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2520027760 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520028194 |
CHM
|
Health Risk |
Likely pathogenic |
Choroideremia, Choroideremia |
| RS2520028297 |
CHM
|
Health Risk |
Pathogenic |
CHM-related disorder, Choroideremia |
| RS2520029962 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS2520030124 |
ATRX
|
Health Risk |
Likely pathogenic |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS2520032988 |
ARHGEF9
|
Health Risk |
Likely pathogenic |
— |
| RS2520039276 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2520058084 |
BCOR
|
Health Risk |
Pathogenic |
— |
| RS2520063904 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2520071379 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520071979 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2520072012 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520079176 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2520083089 |
BCOR
|
Health Risk |
Pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS2520090573 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2520092645 |
DEPDC5
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS2520095426 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520095436 |
CHM
|
Health Risk |
Pathogenic/Likely pathogenic |
Choroideremia, Choroideremia |
| RS2520097855 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520098232 |
CHM
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2520098282 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520098357 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2520105884 |
BCOR
|
Health Risk |
Likely pathogenic |
BCOR-related disorder, BCOR-related disorder |
| RS2520112715 |
BCOR
|
Health Risk |
Likely pathogenic |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |